Digital Health Accelerator

Funding, space, mentorship and connections for market and sales development



The Science Center’s Digital Health Accelerator (DHA) supports digital health companies ready to transition from research and development to sales. The program selects promising companies from around the world and provides them with funding, collaborative workspace, professional mentorship, and introductions to key healthcare stakeholders and investors in the Greater Philadelphia region. Competition for the program is fierce – we only accept six to seven companies per class.  Companies are selected by a group of serial entrepreneurs and experts representing hospitals, the pharmaceutical industry, insurers/payers and investors.  Participating companies are accelerated from prototype development to customer acquisition. The Digital Health Accelerator curriculum matches DHA companies to professionals with specific skills to help the companies meet their individual milestones.


New Jobs Created


Generated in Revenue


Raised in follow-on investing
"The DHA is a great community of entrepreneurs-- a well selected group of excellence seekers. The ecosystem means a lot when you are an entrepreneur. The support of the Science Center has also been paramount for our credibility and progress."

- Christina Lopes, Founder & CEO of The One Health Company, participant in the second DHA class

What we provide 

Successful applicants will be ready to establish operations in the Greater Philadelphia region and have a prototype that needs the DHA’s help to grow in the U.S. healthcare market and increase revenue through sales, partnerships and grants. Applicants must be willing to take advantage of the coaching and mentoring provided by the DHA and be willing to submit regular reports on their progress. The DHA will provide additional assistance as follows:

  • Up to $50,000 cash in operational support, to go from research and development into sales
  • Access to lab and incubator space at the Science Center in Philadelphia
  • Guidance in developing relevant business opportunities in the Greater Philadelphia market and beyond
  • Warm introductions to appropriate decision makers within your target market
  • Expert feedback and recommendations for company presentations and materials
  • Mentorship to complement expertise and operational gaps
  • Support and advice on capitalization, attracting investment, and increasing revenues, customized to each company
  • Introductions to the appropriate advisors, mentors, consultants, and support
  • Access to investors

Who Should Apply?


Applicants will have a product at least at prototype stage, and be ready, during the period of the award, to deploy it to generate initial sales or partnerships, or to scale sales and marketing efforts. Awards will be granted to companies that best demonstrate the following characteristics through existing or planned activities. We will look for these elements in our selections, but not every company will have all of these characteristics:


  • Focus on digital health solutions that are transformative, improve patient care and safety, and enhance wellness and patient independence    
  • Willingness to form partnerships with university and/or other affiliates
  • Ability to create jobs in the Greater Philadelphia region
  • History of revenue generation or the ability to provide matching source of investment
  • Pennsylvania-based operations during the funding period
  • Funds expended in the Greater Philadelphia region


The application deadline is May 15, 2017

If you are unsure if you are a digital health company at the right stage of development to apply, or if you have other questions, please contact Program Manager Aron Starosta at DHA [at] 

Current DHA Companies


Imagine enrolling your ill pet in a clinical trial – for free. Or getting treatment for a chronic wound without going to the doctor’s office. These technologies are among those being developed by the six promising startups in the second class of the Digital Health Accelerator (DHA). They were selected from among a field of companies from all over the country, and the world.


The DHA received funding from the U.S. Small Business Administration to support its second class and to continue its policy of inclusion. Of the six companies in the second DHA class, three are women- or minority-owned. 

2016 DHA Class: 

  • Grand Round Table emails primary care providers a daily summary about their scheduled patient follow-ups so they can better manage high-risk patients, keeping them out of the hospital.

  • Graphwear Technologies has developed the first graphene patch which measures dehydration, glucose, and lactic acid levels, all from your sweat.
  • InvisAlert Solutions uses a wearable device to help care providers monitor patients in institutional settings, improving compliance.
  • Oncora Medical has a tool for planning personalized cancer radiotherapy that reduces the incidence of toxic radiation side effects in patients and improves cancer center efficiency.
  • The One Health Company helps to enroll ill pets in trials of cutting-edge therapies, improving their wellness and helping to develop new therapies for human medicine.
  • Tissue Analytics transforms the smartphone into a platform for evaluating and measuring things like chronic wounds, burns, and skin conditions. 

Digital Health Accelerator of the University City Science Center

2014 Inaugural Class

  • Biomeme enables anyone to do mobile real-time DNA analysis.  
  • Curbside Care is the Uber for healthcare delivery – housecalls are back!  
  • Fever Smart is a smart patch thermometer that allows for continuous and remote temperature monitoring.  
  • Fitly’s SmartPlate instantly analyzes your entire meal with up to 99% accuracy. 
  • Keosys (France) helps multicenter clinical trials manage, centralize and assess medical imaging. 
  • Pulse InfoFrame (Canada) transforms clinical data into the patient information that powers decisions, improves outcomes and advances research. 
  • UE Life Sciences develops innovative yet low-cost and easy-to-use medical devices for breast cancer detection for underserved populations like women in developing countries and women with dense breasts.

DHA Partners


The Digital Health Accelerator is funded in part by a grant from the U.S. Small Business Administration (SBA) Growth Accelerator Fund. The DHA has also received support from the Commonwealth of Pennsylvania’s Department of Community and Economic Development.


The Selection Committee includes representatives from:


  • Carter Ledyard & Milburn LLP / Investors Circle
  • Comcast
  • Cross Valley Capital
  • DDR Partners
  • Drexel University
  • Fitly  (DHA Alumnus)
  • Global Center for Medical Innovation 
  • Goldman Law Associates
  • Hewlett Packard 
  • Independence Blue Cross
  • Johnson & Johnson
  • Results Repeat
  • Safeguard Scientifics
  • SG3 Ventures
  • St. Luke's University Health Network
  • University City Science Center 


Additional Speakers/Mentors:

  • Temir Alimov – Consultant, software and app development
  • Kevin Drucker – Baer, Crossey, McDemus
  • Wayne Dudley – Lexis-Nexis Risk Solutions
  • Jenn Hartt – Ben Franklin Technology Partners of Southeastern PA 
  • Patrick Kelly – Riverside Law
  • Larry Portnoff – AI Advisor, Inc. 
  • Ellen Weber – Robin Hood Ventures/Temple University Innovation & Entrepreneurship Institute 

Questions about the Digital Health Accelerator?  

 The Science Center relies on the generous support of its donors to deliver innovative programs like the DHA. Your tax-deductible gift helps us move ideas forward.